Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1971 Jul;9(1):45–56.

Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumour cells*

M E Oren, R B Herberman
PMCID: PMC1713000  PMID: 5559094

Abstract

Autochthonous tumour cell membrane extracts produced delayed hypersensitivity reactions in patients with a variety of neoplastic diseases. When tested at low protein concentrations (≤0·33 mg/0·1 ml), autochthonous tumour extracts produced positive reactions in 50% of non-anergic cancer patients. The same dose of autochthonous leucocyte membranes produced a significantly lower incidence of positive reactions (10%) in normal volunteers. In contrast, the cancer patients were less reactive than the normal volunteers to a battery of standard skin test antigens. In patients with acute lymphocytic leukaemia, positive reactions were more often obtained during remission. The protein concentration of the extracts was found to be an important factor in these studies. Extracts with high protein concentrations elicited positive reactions in both the patients and in the normal volunteers. It remains to be determined whether the reactions to the high protein concentrations are due to non-specific inflammation or to a low level of autoimmunity in both patients and controls.

Full text

PDF
45

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOYDEN S. AUTOIMMUNITY AND INFLAMMATION. Nature. 1964 Jan 11;201:200–201. doi: 10.1038/201200a0. [DOI] [PubMed] [Google Scholar]
  2. BRENT L., BROWN J., MEDAWAR P. B. Skin transplantation immunity in relation to hypersensitivity. Lancet. 1958 Sep 13;2(7046):561–564. doi: 10.1016/s0140-6736(58)90202-2. [DOI] [PubMed] [Google Scholar]
  3. Bloom B. R., Bennett B. Migration inhibitory factor associated with delayed-type hypersensitivity. Fed Proc. 1968 Jan-Feb;27(1):13–15. [PubMed] [Google Scholar]
  4. Boone C. W., Ford L. E., Bond H. E., Stuart D. C., Lorenz D. Isolation of plasma membrane fragments from HeLa cells. J Cell Biol. 1969 May;41(2):378–392. doi: 10.1083/jcb.41.2.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boss J. H., Silber E., Nelken D. Patterns of naturally occurring circulating antibodies to rat tissue antigens in the rat. Pathol Microbiol (Basel) 1968;31(1):1–13. doi: 10.1159/000161999. [DOI] [PubMed] [Google Scholar]
  6. Brown R. S., Haynes H. A., Foley H. T., Godwin H. A., Berard C. W., Carbone P. P. Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients. Ann Intern Med. 1967 Aug;67(2):291–302. doi: 10.7326/0003-4819-67-2-291. [DOI] [PubMed] [Google Scholar]
  7. Churchill W. H., Jr, Rapp H. J., Kronman B. S., Borsos T. Detection of antigens of a new diethylnitrosamine-induced transplantable hepatoma by delayed hypersensitivity. J Natl Cancer Inst. 1968 Jul;41(1):13–29. [PubMed] [Google Scholar]
  8. David J. R. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A. 1966 Jul;56(1):72–77. doi: 10.1073/pnas.56.1.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Davies D. A. Mouse histocompatibility isoantigens derived from normal and from tumour cells. Immunology. 1966 Aug;11(2):115–125. [PMC free article] [PubMed] [Google Scholar]
  10. Fass L., Herberman R. B., Ziegler J. L., Kiryabwire J. W. Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cells. Lancet. 1970 Jan 17;1(7638):116–118. doi: 10.1016/s0140-6736(70)90467-8. [DOI] [PubMed] [Google Scholar]
  11. Fass L., Herberman R. B., Ziegler J. Delayed cutaneous hypersensitivity reactions to autologous extracts of Burkitt-lymphoma cells. N Engl J Med. 1970 Apr 2;282(14):776–780. doi: 10.1056/NEJM197004022821404. [DOI] [PubMed] [Google Scholar]
  12. GREENWALT T. J., GAJEWSKI M., McKENNA J. L. A new method for preparing buffy coat-poor blood. Transfusion. 1962 Jul-Aug;2:221–229. doi: 10.1111/j.1537-2995.1962.tb00228.x. [DOI] [PubMed] [Google Scholar]
  13. HUGHES L. E., LYTTON B. ANTIGENIC PROPERTIES OF HUMAN TUMOURS: DELAYED CUTANEOUS HYPERSENSITIVITY REACTIONS. Br Med J. 1964 Jan 25;1(5377):209–212. doi: 10.1136/bmj.1.5377.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Herberman R. B. Studies on the specificity of human cytotoxic antibody reactive with cultures of lymphoid cells. J Natl Cancer Inst. 1969 Jan;42(1):69–75. [PubMed] [Google Scholar]
  15. Hollinshead A., Glew D., Bunnag B., Gold P., Herberman R. Skin-reactive soluble antigen from intestinal cancer-cell-membranes and relationship to carcinoembryonic antigens. Lancet. 1970 Jun 6;1(7658):1191–1195. doi: 10.1016/s0140-6736(70)91784-8. [DOI] [PubMed] [Google Scholar]
  16. Kahan B. D. Cutaneous hypersensitivity reactions of guinea pigs to proteinaceous transplantation antigen. J Immunol. 1967 Dec;99(6):1121–1127. [PubMed] [Google Scholar]
  17. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  18. Mann D. L., Rogentine G. N., Jr, Fahey J. L., Nathenson S. G. Solubilization of human leucocyte membrane isoantigens. Nature. 1968 Mar 23;217(5134):1180–1181. doi: 10.1038/2171180a0. [DOI] [PubMed] [Google Scholar]
  19. McCollester D. L., Semente G. Membrane isolation and cytoskeletal breakdown. II. Enzyme studies revealing cytoskeletal stabilization by FAD. Exp Cell Res. 1966 May;42(2):209–217. doi: 10.1016/0014-4827(66)90284-9. [DOI] [PubMed] [Google Scholar]
  20. McDuffie F. C. Autoantibodies in healthy subjects. Ann Intern Med. 1970 Apr;72(4):596–597. doi: 10.7326/0003-4819-72-4-596. [DOI] [PubMed] [Google Scholar]
  21. Stewart T. H. The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 1. The role of tissue antigen, nonspecific reactions of nuclear material, and bacterial antigen as a cause for this phenomenon. Cancer. 1969 Jun;23(6):1368–1379. doi: 10.1002/1097-0142(196906)23:6<1368::aid-cncr2820230619>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  22. Stewart T. H. The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 2. A correlation between the histologic picture of lymphocyte infiltration of the tumor stroma, the presence of such a reaction, and a discussion of the significance of this phenomenon. Cancer. 1969 Jun;23(6):1380–1387. doi: 10.1002/1097-0142(196906)23:6<1380::aid-cncr2820230620>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  23. Ward P. A., Remold H. G., David J. R. Leukotactic factor produced by sensitized lymphocytes. Science. 1969 Mar 7;163(3871):1079–1081. doi: 10.1126/science.163.3871.1079. [DOI] [PubMed] [Google Scholar]
  24. Weir D. M., Elson C. J. Antitissue antibodies and immunological tolerance to self. Arthritis Rheum. 1969 Jun;12(3):254–260. doi: 10.1002/art.1780120314. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES